ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2016

Abstract Number: 2462

Higher Number of Tender Than Swollen Joint Count Is Associated to Higher Patient Reported Outcomes and Composite Scores As Well As Reduced Probability of Obtaining Remission: Results from a One-Year Follow-up Study of Established RA Patients Starting Bdmards

Hilde Berner Hammer1,2, Till Uhlig1, Tore K. Kvien1,2 and Jon Lampa3, 1Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Dept of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 3Dep of Medicine, Rheumatology unit, Karolinska Institute, Karolinska Institute, Stockholm, Sweden

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2016

Date of first publication: September 28, 2016

Keywords: remission and rheumatoid arthritis (RA)

Session Information

Date: Tuesday, November 15, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster III: Treatment – Monitoring, Outcomes, Adverse Events

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  The swollen and tender joint count is included in composite scores (DAS28, CDAI, SDAI, ACR/EULAR Boolean remission). Low swollen/tender joint ratio (STR) has been found to be associated with reduced clinical response[1]. Ultrasound (US), including grey scale (GS) synovitis and power Doppler (PD) assessment of vascularity is sensitive for detecting inflammatory activity. Presently we explored associations between STR and pain catastrophizing, PROs, composite scores, clinical evaluation and US assessments, and more importantly, with composite score remission, in a follow-up study of established RA patients initiating bDMARDs.

Methods: 209 patients with RA (mean (SD) age 53 (13) years, disease duration 10 (9) years, 81% women, 79% anti-CCP positive) were included when initiating bDMARDs and assessed at baseline and after 1, 2, 3, 6 and 12 months with PROs (joint pain VAS, patient’s global VAS, RAID score and MHAQ), clinical examinations (assessor’s disease activity VAS, tender and swollen joint counts (of 28)) and laboratory variables (ESR and CRP). STRs were calculated with insertion of 1 if 0 in the denominator. Pain catastrophizing was assessed by two questions from the Coping Strategies Questionnaire. All US examinations (semi-quantitative scoring (0-3)) of GS and PD (PIP 2-3, MCP 1-5, wrist (RC, IC, RU), elbow, knee, tibiotalar, MTP 1-5 and ext.carpi ulnaris/tib.post.tendons bilaterally) were performed by one rheumatologist (HBH) (Siemens Acuson Antares, excellence version, 5-13 MHz probe). Statistical calculations included Pearson’s correlations, independent samples T-test and cross-tabs for assessing risk levels.

Results: There was a wide distribution of STR levels (median 1.0 (IQR 0.6-2.5), mean (SD) 2.4 (3.8)). During follow-up there were no/low cross-sectional correlations between STR and all the PROs and laboratory markers (r= -0.03-0.24), but moderate to high correlations with assessor’s global (r= 0.27-0.42, p<0.001) and the US examinations (GS; r=0.48-0.63/PD; r=0.38-0.67, p<0.001). Patients were divided into groups with STR ≥ 1.0 or <1.0. The table (including mean values) shows that patients with STR<1.0 during follow-up had significantly higher levels of PROs and composite scores but lower US scores. Patients with STR < 1.0 achieved less often remission according to the composite scores (STR<1.0/STR≥1; DAS28 4.3%/36.4% and 3.3%/35.5%, CDAI 2.7%/17.9% and 1.3%/23.7%, SDAI 3.3%/20.1% and 3.3%/24.3%/, Boolean 2.7%/18.5% and 1.3%/21.7% at 6 and 12 months, respectively).

Conclusion: Established RA patients with higher number of tender than swollen joint count had higher levels of PROs and composite scores, but lower US pathology, and more importantly, lower achievement of clinical remission. Thus, these patients may have a trait including higher subjective scores, which is relevant within the treat-to-target strategy. Reference: Kristensen LE et al, Arthritis Care Res 2014 Feb;66(2):173-9


Disclosure: H. B. Hammer, None; T. Uhlig, None; T. K. Kvien, None; J. Lampa, None.

To cite this abstract in AMA style:

Hammer HB, Uhlig T, Kvien TK, Lampa J. Higher Number of Tender Than Swollen Joint Count Is Associated to Higher Patient Reported Outcomes and Composite Scores As Well As Reduced Probability of Obtaining Remission: Results from a One-Year Follow-up Study of Established RA Patients Starting Bdmards [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/higher-number-of-tender-than-swollen-joint-count-is-associated-to-higher-patient-reported-outcomes-and-composite-scores-as-well-as-reduced-probability-of-obtaining-remission-results-from-a-one-year-f/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/higher-number-of-tender-than-swollen-joint-count-is-associated-to-higher-patient-reported-outcomes-and-composite-scores-as-well-as-reduced-probability-of-obtaining-remission-results-from-a-one-year-f/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology